The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeptune-Calculus Income & Growth Regulatory News (NEP)

  • There is currently no data for NEP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

14 Aug 2014 18:27

RNS Number : 2128P
Neptune-Calculus Income &Growth VCT
14 August 2014
 



INTERIM RESULTS FOR 6 MONTHS TO 30 JUNE 2014

 

 

CORPORATE POLICY AND PERFORMANCE SUMMARY

Objective

Neptune-Calculus Income and Growth VCT ('the Company') is a Venture Capital Trust listed on the London Stock Exchange which has the objective of generating long term capital growth and tax free dividends for investors. The Company is managed as a VCT in order that shareholders may benefit from the tax reliefs available.

The Company's investment policy is to invest approximately 75 per cent of the Company's funds in a diversified portfolio of holdings in qualifying investments whether unquoted or traded on the Alternative Investment Market ('AIM'). Investments are made selectively across a diverse range of sectors in companies which have the potential to generate growth and enhance their value. The Company does not invest in start-up and seed capital situations. The qualifying investments are managed by Calculus Capital Limited ('Calculus'), and the balance of the Company's investments can be invested in a combination of Neptune income funds and a portfolio of similar income generating UK listed shares and money market instruments.

Financial highlights

Six months to30 June2014

Return per Ordinary Share

0.3

p

Net asset value per Ordinary Share

46.8

p

Cumulative dividends paid per Ordinary Share

24.5

p

Accumulated shareholder value

71.3

p

Proposed interim dividend

1.0

p

 

Accumulated shareholder value represents net asset value per share plus cumulative dividends paid per share.

As at31 July 2014

*

Net asset value per Ordinary Share+

46.4

p

 

*Being the latest practicable date prior to publication.

+Including current period revenue.

 

CHAIRMAN'S STATEMENT

I present your Company's results for the six months ended 30 June 2014. Net assets per Ordinary Share on 30 June 2014 were 46.8 pence per share compared with 48.5 pence per share as at 31 December 2013. The portfolio saw an increase in value over the period but a major part of the movement is attributable to the dividend of 2.0 pence per Ordinary Share paid in June 2014. This dividend payment took the total cumulative dividends paid on the Ordinary Shares since inception to 24.5 pence per share.

Our qualifying investments, which include both unquoted and AIM companies, are managed by Calculus. Over the period under review, the overall value of the quoted companies rose on a like-for-like basis by approximately 1.3 per cent, compared with a decrease in the AIM market of 7.7 per cent. The value of the unquoted portfolio increased by 7.6 per cent during the period due to an increase in the value of Terrain Energy Limited ('Terrain').

There has been one new investment in the period. A short term loan facility of £100,000 was made available to Lime Technology Limited ('Lime') to facilitate a move away from use of an invoice discounting facility further details of which are disclosed in the Investment Manager's Report.

In February 2014, MicroEnergy Generation Services Limited ('MicroEnergy') redeemed £70,000 loan stock held by the Company at par. The sale proceeds were used towards paying the final 2013 dividend for the year ended 31 December 2013 in June 2014.

In March 2014, the Company accepted an offer made to all shareholders in respect of Expansys plc.

Our non-qualifying investments principally comprise holdings in the Neptune Income Fund and Neptune Quarterly Income Fund which decreased by 3.7 per cent on a like for like basis over the period. At 30 June 2014, the Company also held certain investments in portfolio companies which are non-qualifying and £3,000 in cash funds, as shown in the Investment Portfolio.

A more detailed analysis of qualifying investment performance can be found in the Investment Manager's Review following this statement.

Developments since the period end

In July 2014, the Company sold its holding of ordinary shares and preference shares in Triage Holdings Limited ('Triage') and £10,000 of its loan facility to Triage was repaid above its carrying value. The remaining loan facility will be repaid in two equal annual tranches in 2015 and 2016.

Also in July 2014, the Company made a further short term loan facility of £35,000 available to Lime.

Dividends

The 2013 final dividend of 2.0 pence per Ordinary Share was paid in June 2014 following shareholder approval at the AGM. In line with our policy of maximising tax-free dividends to shareholders, the Directors are pleased to declare an interim dividend of 1 penny per Ordinary Share, payable on 15 October 2014 to shareholders on the register on 19 September 2014.

Outlook

UK economic conditions have improved during the first six months of the year and we believe the investments in the portfolio are well placed to benefit from a stronger economy.

Philip Stephens

Chairman14 August 2014

 

 

INVESTMENT MANAGER'S REVIEW (QUALIFYING INVESTMENTS)

Calculus advises the Company in respect of qualifying investments made by the Company.

Portfolio developments

At 30 June 2014 the portfolio of qualifying investments comprised 14 companies made up of both AIM quoted and unquoted stocks. The Company continues to meet the requirements for approved VCT status.

We are pleased to report that the quoted portfolio went up in value by 1.3 per cent compared with a decrease in the AIM market of 7.7 per cent.

At the period end, EpiStem Holdings plc ('EpiStem') is valued at over 2.5 times initial cost. EpiStem is a biotechnology company commercialising its expertise in adult stem cells in the areas of infectious and epithelial disease. EpiStem's Genedrive, a handheld rapid diagnostics device, is undergoing regulatory approval for tuberculosis ('TB') in India where TB has reached epidemic proportions (with an estimated 2-3 million cases). In July 2014, the Company entered into a collaborative funding agreement with Global Health Investment Fund 1 ('GHIF') to support the roll out of the Genedrive molecular diagnostics platform. Under the agreement, GHIF, which is partially backed by the Bill and Melinda Gates Foundation, has invested $8.0m by way of a convertible bond.

InfraStrata plc ('InfraStrata') is an independent petroleum exploration and gas storage company. Significant unrisked P50 prospective resources of 450 million barrels have been identified at the Larne-Lough Neagh basin in Northern Ireland (PL1/10) in which InfraStrata has a 45 per cent interest. The company plans to drill a first exploration well in late 2014. InfraStrata has a portfolio of other conventional and unconventional energy assets onshore in the UK. The company also plans to drill a test well at its Islandmagee gas storage project in the near future.

At 30 June 2014, the value of the unquoted portfolio was £3.5m. The portfolio increased by 7.6 per cent on a like for like basis due to an increase in the carrying value of Terrain during the period.

Terrain continues to make good progress. Terrain has interests in nine petroleum licences; Keddington, Kirklington, Dukes Wood and Burton on the Wolds in the East Midlands, Larne, and a licence offshore to the north of Larne, in Northern Ireland, Brockham in Surrey and Bruckmuhl and Starnberger See in Germany. Terrain is currently producing from wells at Keddington and Brockham. On average 70 barrels of oil per day and 50,000 standard cubic feet of gas per day are being produced (gross).

Two exploration wells are planned in 2014 on the Larne and Burton on the Wolds licences. Should the Larne well be a success it would be game-changing for the company as 450 million barrels of prospective resources have been mapped in the area (45 million barrels net to Terrain). Also this would greatly increase the likelihood of finding commercial oil reserves in the 27th Offshore Round licence to the north of Larne which was awarded by DECC to Terrain and its partners in early 2014. Terrain has a 20 per cent share of the licence.

Waterfall Services Limited ('Waterfall'), which provides catering services to the aged care and education markets, traded significantly ahead of expectations for the year to March 2014. There were a number of contracts up for retender in the period and, although there were some losses, the company successfully retained a large contract for Durham primary schools amongst others as well as winning new business through the award of new contracts. In addition Waterfall acquired Pro Serv, a business in the South West with a focus on the education market, which has been integrated and performs well. This strong performance has continued in the current period and, looking forward, the company is also positioned to benefit from the Universal Free School Meals for Infants to be introduced from September 2014.

During the period, MicroEnergy redeemed £70,000 of its loan stock. MicroEnergy owns and operates a fleet of small onshore wind turbines (

RMS, which provides port services on the Humber and Trent, continues to perform well and has exceeded its budget for the first six months of 2014.

Lime is a low carbon based building materials developer. A new Chief Operation Officer was appointed in March 2014 and, as a consequence, the business has seen a number of personnel changes. Particular focus has been placed on improving margins across the group. Lime won the prestigious Ashden Award in the 'sustainable buildings' category and won a key contract with Bouygues UK for Vicars Green School. The increase in activity across divisions, including the External Wall Insulation (EWI) division, has placed a strain on working capital.

During the period, a short term loan facility of £100,000 was made available to Lime to facilitate a move away from use of an invoice discounting facility where the terms and conditions were judged too onerous and expensive. This short term facility is secured on any sums receivable by the company from HM Revenue & Customs by way of Research and Development Relief for Corporation Tax ('sums receivable').

UK based payments technology company, Secure Electrans Limited, was placed in administration in March 2014 when it was unable to demonstrate adequate visibility over future working capital needs and secure funding. We continue to value the loan stock, some of which is secured on the intellectual property (IP) portfolio, at par as we believe the realisation from the sale of the IP portfolio is likely to cover outstanding loans.

Developments since the period end

The holding of ordinary shares and preference shares in Triage were sold in July 2014 and £10,000 of its loan facility was repaid for a consideration slightly ahead of carrying value. The remaining loan facility will be repaid in two equal annual tranches in 2015 and 2016.

Also in July 2014, the Company made a further short term facility of £35,000 available to Lime secured on sums receivable.

Other than disclosed above, there have not been any significant developments in the qualifying portfolio since the period end.

 

 

John Glencross

Calculus Capital Limited

 

 

14 August 2014

 

INVESTMENT PORTFOLIO

The ten largest holdings by value are included below:

Cost

Valuation

Percentage

of portfolio

£

£

%

AIM investments (quoted equity)

EpiStem Holdings pic*

251,261

667,138

12.6%

Other AIM investments*

450,940

22,147

0.4%

Unquoted equity investments

Terrain Energy Limited*

413,633

866,622

16.4%

RMS Group Holdings Limited

100,044

598,717

11.3%

Waterfall Services Limited

50,129

568,387

10.7%

Lime Technology Limited*

234,285

97,094

1.8%

Human Race Group Limited

100,000

86,793

1.7%

Secure Electrans Limited

250,000

-

0.0%

Triage Holdings Limited*

50,589

-

0.0%

Other unquoted equity investments*

1,092,993

143,625

2.7%

Unquoted preference shares

Triage Holdings Limited preference shares

265,013

38,727

0.7%

Unquoted bonds

Lime Technology Limited loan stock#*

351,544

351,544

6.6%

Lime Technology Limited loan facility

100,000

100,000

1.9%

Human Race Group Limited loan stock

300,000

300,000

5.7%

Secure Electrans Limited loan stock

222,000

222,000

4.2%

Triage Holdings limited loan facility

74,280

85,057

1.6%

Other unquoted bonds†

575,436

75,000

1.4%

Non-qualifying equity investments and loan stock*†#

(446,501)‌‌

(127,485)‌‌

(2.4%) ‌‌

Total qualifying investments

4,435,646

4,095,366

77.3%

Quoted funds

Neptune Income Fund Income A Class

485,549

534,370

10.1%

Neptune Quarterly lncome Fund Income Units

500,708

535,175

10.1%

Unquoted funds

3,146

3,146

0.1%

Non-qualifying equity investments and loan stock*†#

446,501

127,485

2.4%

Total non-qualifying investments

1,435,904

1,200,176

22.7%

Total investments

5,871,550

5,295,542

100.0%

 

* The valuations of certain investments include small non-qualifying investments. These cost £120,839 and are valued at £110,941.

# The valuation of Lime Technology Limited loan stock includes rolled up interest that is non-qualifying. This cost £16,544 and is valued at £16,544.

† The valuation of Heritage House Media Limited loan stock includes rolled up interest which is non-qualifying. This cost £309,118 and is valued at £nil.

 

UNAUDITED INCOME STATEMENT

for the six months to 30 June 2014

Six months to30 June2014

Six months to30 June2013

Year to

31 December2013*

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

Note

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Gains/(losses) on investments at fair value

-

74

74

-

106

106

-

(521)‌‌

(521)‌‌

Investment income

46

-

46

81

-

81

134

-

134

Investment

management fee

(4)‌‌

(13)‌‌

(17)‌‌

(12)‌‌

(34)‌‌

(46)‌‌

(15)‌‌

(45)‌‌

(60)‌‌

Other expenses

(75)‌‌

-

(75)‌‌

(63)‌‌

-

(63)‌‌

(131)‌‌

-

(131)‌‌

(Deficit)/return on ordinary activities before taxation

(33)‌‌

61

28

6

72

78

(12)‌‌

(566)‌‌

(578)‌‌

Taxation on ordinary activities

-

-

-

-

-

-

-

-

-

(Deficit)/return attributable to Ordinary shareholders

(33)‌‌

61

28

6

72

78

(12)‌‌

(566)‌‌

(578)‌‌

(Deficit)/return per Ordinary Share

3

(0.29)p

0.54p

0.25p

0.05p

0.64p

0.69p

(0.10)p

(5.00)p

(5.10)p

 

\* These figures are audited.

 

The total column of this statement is the profit and loss account of the Company. The revenue and capital columns are provided as supplementary information in accordance with The Association of Investment Companies Statement of Recommended Practice.

All items in the above statement derive from continuing operations. No operations were acquired or discontinued in the period.

There is no statement of recognised gains and losses as there were no other gains and losses.

The relevant accompanying notes are an integral part of this statement.

 

UNAUDITED RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS

for the six months to 30 June 2014

Share capital

Share premium

Special reserve

Capital redemption reserve

Capitalreserve

Revenue reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

For the period 1 January 2014to 30 June 2014

1 January 2014

1,131

-

8,695

510

(4,851)‌‌

1

5,486

Net return/(deficit) after taxationfor the period

-

-

-

-

61

(33)‌‌

28

Dividends paid

-

-

(225)‌‌‌‌

-

-

‌‌(1)‌‌

(226)‌‌‌‌

30 June 2014

1,131

-

8,470

510

(4,790)‌‌‌‌

(33)‌‌

5,288

For the period 1 January 2013to 30 June 2013

1 January 2013

1,135

631

8,809

105

(4,285)‌‌‌‌

39

6,434

Shares issued

401

1,867

-

-

-

-

2,268

Share issue costs

-

(50)‌‌

-

-

-

-

(50)‌‌

Purchase of own shares

(405)‌‌‌‌

-

(2,233)‌‌‌‌

405

-

-

(2,233)‌‌‌‌

Net return after taxationfor the period

-

-

-

-

72

6

78

Dividends paid

-

-

(189)‌‌‌‌

-

-

(38)‌‌‌‌

(227)‌‌‌‌

30 June 2013

1,131

2,448

6,387

510

(4,213)‌‌‌‌

7

6,270

For the year 1 January 2013to 31 December 2013*

1 January 2013

1,135

631

8,809

105

(4,285)‌‌‌‌

39

6,434

Shares issued

401

1,867

-

-

-

-

2,268

Share issue costs

-

(50)‌‌

-

-

-

-

(50)‌‌

Purchase of own shares

(405)‌‌‌‌

-

(2,233)‌‌‌‌

405

-

-

(2,233)‌‌‌‌

Net deficit after taxationfor the year

-

-

-

-

(566)‌‌

(12)‌‌

(578)‌‌

Dividends paid

-

-

(314)‌‌‌‌

-

-

(26)‌‌‌‌

(340)‌‌‌‌

Share premium cancellation

-

(2,448)‌‌

2,448

-

-

-

-

Share premium cancellation costs

-

-

(15)‌‌

-

-

-

(15)‌‌

31 December 2013*

1,131

-

8,695

510

(4,851)‌‌

1

5,486

 

\* These figures are audited.

 

The relevant accompanying notes are an integral part of this statement.

 

UNAUDITED BALANCE SHEET

as at 30 June 2014

30 June

2014

30 June

2013

31 December2013*

Note

£'000

£'000

£'000

Fixed Assets

Investments at fair value through profit or loss

5,296

6,235

5,423

Current Assets

Debtors

14

43

23

Cash at bank

35

84

88

49

127

111

Creditors: Amounts falling due within one year

Creditors

(57)‌‌

(92)‌‌‌‌

(48)‌‌

Net Current (Liabilities)/Assets

(8)‌‌

35

63

Net Assets

5,288

6,270

5,486

Represented by:

CALLED UP SHARE CAPITAL AND RESERVES

Share capital

5

1,131

1,131

1,131

Share premium

-

2,448

-

Special reserve

8,470

6,387

8,695

Capital redemption reserve

510

510

510

Capital reserve - other

(4,214)‌‌

(3,888)‌‌‌‌

(3,757)‌‌

Capital reserve - investment holding loss

(576)‌‌

(325)‌‌‌‌

(1,094)‌‌

Revenue reserve

(33)‌‌

7

1

Total Ordinary shareholders' funds

5,288

6,270

5,486

Net asset value per Ordinary Share

4

46.75p‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌

55.43p‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌

48.50p

 

\* These figures are audited.

 

The relevant accompanying notes are an integral part of this statement.

 

UNAUDITED CASH FLOW STATEMENT

for the six months to 30 June 2014

Six monthsto 30 June2014

Six monthsto 30 June2013

Year to31 December 2013*

Note

£'000

£'000

£'000

Operating activities

Investment income received

45

73

160

Investment management fees paid

-

(45)‌‌‌‌

(117)‌‌

Administration fees paid

-

(10)‌‌‌‌

(24)‌‌

Other cash payments

(73)‌‌

(58)‌‌‌‌

(113)‌‌

Net cash outflow from operating activities

6

(28)‌‌

(40)‌‌‌‌

(94)‌‌

Investing activities

Purchase of investments

(100)‌‌

(197)‌‌‌‌

(857)‌‌

Sale of investments

301

499

1,345

Net cash inflow from investing activities

201

302

488

Equity dividends paid

(226)‌‌

(227)‌‌‌‌

(340)‌‌

Financing

Purchase of own shares

-

(2,222)‌‌‌‌

(2,233)‌‌

Net proceeds of Ordinary Share issue

-

2,207

2,268

Share issue costs

-

-

(50)‌‌

Share premium cancellation costs

-

-

(15)‌‌

Net cash outflow from financing

-

(15)‌‌‌‌

(30)‌‌

(Decrease)/increase in cash for the period

(53)‌‌

20

24

 

\* These figures are audited.

 

The relevant accompanying notes are an integral part of this statement.

 

CONDENSED NOTES TO THE ACCOUNTS

1 Nature of Financial Information

The unaudited half-yearly financial information does not constitute statutory financial statements as defined in Section 434 of the Companies Act 2006 and has not been reviewed nor audited by the auditors. This information has been prepared on the basis of the accounting policies used in the statutory financial statements of the Company for the year ended 31 December 2013. The statutory financial statements for the year ended 31 December 2013, which contained an unqualified auditors' report, have been lodged with the Registrar of Companies, did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying the report and did not contain statements under Section 498(2) or (3) of the Companies Act 2006.

2 Dividends

The Directors have declared an interim dividend of 1 penny per Ordinary Share. This dividend is payable on 15 October 2014 to shareholders on the register on 19 September 2014.

3 Return per Ordinary Share

Six months to

30 June 2014

Six months to

30 June 2013

Year to

31 December 2013

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

pence

pence

pence

pence

pence

pence

pence

pence

pence

Ordinary Share

(0.29)‌‌

0.54

0.25

0.05

0.64

0.69

(0.10)‌‌

(5.00)‌‌

(5.10)‌‌

 

Revenue return per Ordinary Share is based on the net deficit on ordinary activities attributable to the Ordinary Shares of £33,000 (30 June 2013: net return £6,000, 31 December 2013: net deficit £12,000) and on 11,311,329 (30 June 2013: 11,346,503, 31 December 2013: 11,328,771) Ordinary Shares, being the weighted average number of Ordinary Shares in issue during the period.

Capital return per Ordinary Share is based on the net capital return for the period of £61,000 (30 June 2013: net capital return £72,000, 31 December 2013: net capital deficit £566,000) and on 11,311,329 (30 June 2013: 11,346,503, 31 December 2013: 11,328,771) Ordinary Shares, being the weighted average number of Ordinary Shares in issue during the period.

Total return per Ordinary Share is based on the total return on ordinary activities attributable to the Ordinary Shares of £28,000 (30 June 2013: net return £78,000, 31 December 2013: net deficit £578,000) and on 11,311,329 (30 June 2013: 11,346,503, 31 December 2013: 11,328,771) Ordinary Shares, being the weighted average number of Ordinary Shares in issue during the period.

4 Net asset value per Ordinary Share

30 June2014

30 June

2013

 31 December 2013

pence

pence

pence

Ordinary Shares of 10p each

46.75

55.43

48.50

 

The basic net asset value per Ordinary Share is based on net assets (including current period revenue) of £5,288,000 (30 June 2013: £6,270,000, 31 December 2013: £5,486,000) and on 11,311,329 (30 June 2013: 11,311,329, 31 December 2013: 11,311,329) Ordinary Shares, being the number of Ordinary Shares in issue at the end of the period.

5 Called up share capital

Ordinary Shares

Issued and fully paid:

Six months to30 June 2014

Six months to30 June 2013

Year to31 December 2013

Ordinary Shares of 10p each

Number

£'000

Number

£'000

 Number

£'000

As at 1 January

11,311,329

1,131

11,351,880

1,135

11,351,880

1,135

Purchase of shares

-

-

(4,052,635)‌‌

(405)‌‌

(4,052,635)‌‌

(405)‌‌

Shares issued

-

-

4,012,084

401

4,012,084

401

As at 30 June

11,311,329

1,131

11,311,329

1,131

11,311,329

1,131

 

During the period, the Company did not issue or purchase for cancellation any Ordinary Shares. During the period ended 30 June 2013, pursuant to an Enhanced Share Buyback, 4,052,635 Ordinary Shares of 10p were purchased for cancellation at 54.83 pence per share for which the consideration was £2,233,175 including stamp duty of £11,115. Pursuant to the Enhanced Share Buyback, the Company issued 3,930,990 Ordinary Shares at 56.53 pence per share and a further 81,094 Ordinary Shares were issued pursuant to a Top Up Offer at the same price.

6 Reconciliation of net return/(deficit) before taxation to net cash outflow from operating activities

Six months to30 June

2014

Six months to30 June2013

Year to 31 December 2013

£'000

 £'000

 £'000

Net return/(deficit) before taxation

28

78

(578)‌‌

Net capital (return)/deficit

(61)‌‌

(72)‌‌‌‌

566

Decrease/(increase) in debtors

9

(7)‌‌‌‌

12

Increase/(decrease) in creditors

9

(5)‌‌‌‌

(49)‌‌

Investment management fee charged to capital

(13)‌‌

(34)‌‌‌‌

(45)‌‌

Net cash outflow from operating activities

(28)‌‌

(40)‌‌‌‌

(94)‌‌

 

7 Related party transactions

The Company's qualifying investments are managed by Calculus. John Glencross, a Director of the Company, has an interest in Calculus.

Six months to30 June2014

Six months to30 June 2013

Year to31 December 2013

£'000

£'000

£'000

Investment management and administration fees

17

46

60

 

Calculus receives annual fees from Terrain and Lime for the provision of John Glencross as a Director, as well as annual monitoring fees. Calculus also receives annual fees from Hampshire Cosmetics Limited ('Hampshire') for the provision of a director, as well as annual monitoring fees. Calculus receives an annual monitoring fee from MicroEnergy and Human Race Group Limited ('Human Race'). Calculus also receives fees for the provision of a director to Dryden Human Capital Limited ('Dryden'). Other funds under the management or advice of Calculus have also invested in Terrain, Lime, MicroEnergy, Hampshire, Human Race and Dryden. In the six months to 30 June 2014, the amount payable to Calculus which was attributable to the investment made by the Company was £1,250 (30 June 2013: £2,671; 31 December 2013: £4,519) (excluding VAT) from Terrain, £2,301 (30 June 2013: £1,751; 31 December 2013: £2,889) (excluding VAT) from Lime, £179 (30 June 2013: £334; 31 December 2013: £674) (excluding VAT) from MicroEnergy, £1,682 (30 June 2013: £1,516; 31 December 2013: £3,295) (excluding VAT) from Human Race, £367 from Hampshire (30 June 2013 £0; 31 December 2013: £0) (excluding VAT) and £1,514 (30 June 2013: £0; 31 December 2013: £608) (excluding VAT) from Dryden.

In the six months to 30 June 2014 Calculus received no arrangement fees (30 June 2013: £510; 31 December 2013: £170) in respect of investments made by the Company.

 

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The half-yearly financial report, which has not been audited or reviewed by auditors pursuant to the Auditing Practices Board Guidance on Review of Half-Yearly Financial Information is the responsibility of, and has been approved by, the Directors. The Directors confirm that to the best of their knowledge the half-yearly financial report, which has been prepared in accordance with the Disclosure and Transparency rules and in accordance with applicable accounting standards including the statement 'Half-yearly financial reports' issued by the UK Accounting Standards Board, gives a true and fair view of the assets, liabilities, financial position and the deficit of the Company as at 30 June 2014.

The Directors confirm that the Chairman's Statement, the Investment Managers' Reviews, and note 7, include a fair review of the information required by DTR 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the financial year, and 4.2.8R of the Disclosure and Transparency Rules.

The Directors of Neptune-Calculus Income and Growth VCT plc are:

Philip Stephens

John Glencross

David Kempton

By order of the Board

Philip Stephens

Chairman

14 August 2014

 

The half yearly report will shortly be posted to shareholders. Copies of the report will also be available from the Company's registered office at 104 Park Street, London, W1K 6NF or from the Qualifying Investment Manager's website at www.calculuscapital.com/neptunevct.aspx.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR GGUWPRUPCGMC
Date   Source Headline
12th Sep 20174:05 pmRNSGM Statement
31st Aug 201712:46 pmRNSGM Statement
4th Aug 20175:57 pmRNSFurther re merger
4th Aug 20175:57 pmRNSMerger and Offer for subscription
10th Jul 20179:06 amRNSResult of AGM
19th Jun 20177:00 amRNSStatement re Recommended Proposals for Merger
19th Jun 20177:00 amRNSStatement re Recommended Proposals for Merger
7th Jun 20179:23 amRNSDirector Declaration
25th Apr 20175:39 pmRNSDirectorate Change
24th Mar 20171:08 pmRNSdividend record date
21st Mar 20176:28 pmRNS2016 results and Annual Financial Report
20th Oct 20165:10 pmRNSNet Asset Value(s)
19th Aug 20163:35 pmRNSHalf-year Report
17th May 20165:25 pmRNSResult of AGM
12th May 20163:46 pmRNSTotal Voting Rights
18th Mar 20163:54 pmRNSTransaction in Own Shares
15th Mar 20166:01 pmRNSAnnual Financial Report
26th Feb 20162:28 pmRNSDisclosure of Home Member State
18th Dec 201511:23 amRNSDirector/PDMR Shareholding
13th Aug 20155:01 pmRNSHalf Yearly Report
19th May 20156:13 pmRNSResult of AGM
20th Mar 20156:11 pmRNSFinal Results
30th Jan 201511:32 amRNSDividend Declaration
22nd Dec 20143:15 pmRNSDisposal
14th Aug 20146:27 pmRNSHalf Yearly Report
23rd May 201412:19 pmRNSAGM Statement
8th May 201412:38 pmRNSInterim Management Statement
4th Apr 20145:30 pmRNSAnnual Information Update
31st Mar 20143:45 pmRNSFinal Results
19th Nov 20133:12 pmRNSInterim Management Statement
15th Aug 201312:59 pmRNSHalf Yearly Report - Replacement
15th Aug 201311:31 amRNSHalf Yearly Report
7th Jun 20132:29 pmRNSTransaction in Own Shares and results of EBB
30th May 20133:54 pmRNSResult of Meeting
16th May 201312:43 pmRNSInterim Management Statement
10th May 20131:13 pmRNSAnnual Information Update
28th Mar 20133:47 pmRNSEBB Top up offer and Notice of meeting
27th Mar 20135:21 pmRNSFinal Results
16th Nov 20129:45 amRNSInterim Management Statement
23rd Aug 20122:33 pmRNSHalf Yearly Report
6th Jun 20123:33 pmRNSResult of AGM
6th Jun 20123:28 pmRNSTotal Voting Rights
16th May 20126:04 pmRNSInterim Management Statement
22nd Mar 20123:26 pmRNSAnnual Information Update
22nd Mar 20122:59 pmRNSTransaction in Own Shares and Annual Report
15th Mar 20124:33 pmRNSFinal Results
18th Nov 20114:54 pmRNSInterim Management Statement
17th Aug 20113:23 pmRNSHalf Yearly Report
17th Aug 20112:34 pmRNSTotal Voting Rights
21st Jun 20112:14 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.